TW200533666A - Chemical compounds - Google Patents

Chemical compounds Download PDF

Info

Publication number
TW200533666A
TW200533666A TW093109096A TW93109096A TW200533666A TW 200533666 A TW200533666 A TW 200533666A TW 093109096 A TW093109096 A TW 093109096A TW 93109096 A TW93109096 A TW 93109096A TW 200533666 A TW200533666 A TW 200533666A
Authority
TW
Taiwan
Prior art keywords
alkyl
ring
alkoxy
group
substituents
Prior art date
Application number
TW093109096A
Other languages
English (en)
Chinese (zh)
Inventor
Daniel Robert Carcanague
Michael Barry Gravestock
Sheila Irene Hauck
Thomas Peter Weber
Neil James Hales
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0227702A external-priority patent/GB0227702D0/en
Priority claimed from GB0304725A external-priority patent/GB0304725D0/en
Priority claimed from GB0318608A external-priority patent/GB0318608D0/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of TW200533666A publication Critical patent/TW200533666A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/653Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
TW093109096A 2002-11-28 2004-04-01 Chemical compounds TW200533666A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0227702A GB0227702D0 (en) 2002-11-28 2002-11-28 Chemical compounds
GB0304725A GB0304725D0 (en) 2003-03-01 2003-03-01 Chemical compounds
GB0318608A GB0318608D0 (en) 2003-08-08 2003-08-08 Chemical compounds
PCT/GB2003/005087 WO2004048392A1 (en) 2002-11-28 2003-11-24 Oxazolidinone and / or isoxazoline derivatives as antibacterial agents

Publications (1)

Publication Number Publication Date
TW200533666A true TW200533666A (en) 2005-10-16

Family

ID=32397650

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093109096A TW200533666A (en) 2002-11-28 2004-04-01 Chemical compounds

Country Status (15)

Country Link
US (1) US20060116400A1 (OSRAM)
EP (1) EP1567532A1 (OSRAM)
JP (1) JP2006508192A (OSRAM)
KR (1) KR20050085193A (OSRAM)
AU (1) AU2003302404B2 (OSRAM)
BR (1) BR0316688A (OSRAM)
CA (1) CA2507468A1 (OSRAM)
HK (1) HK1079794A1 (OSRAM)
IL (1) IL168747A0 (OSRAM)
MX (1) MXPA05005651A (OSRAM)
NO (1) NO20052534L (OSRAM)
NZ (1) NZ540147A (OSRAM)
SA (1) SA04250088A (OSRAM)
TW (1) TW200533666A (OSRAM)
WO (1) WO2004048392A1 (OSRAM)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1427711T3 (da) * 2001-09-11 2005-10-17 Astrazeneca Ab Oxazolidinon og/eller isoxazolinderivater som antibakterielle midler
NZ535591A (en) 2002-02-28 2006-07-28 Astrazeneca Ab Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them
WO2003072575A1 (en) 2002-02-28 2003-09-04 Astrazeneca Ab 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents
AR043050A1 (es) 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
GB0227701D0 (en) * 2002-11-28 2003-01-08 Astrazeneca Ab Chemical compounds
MXPA05005522A (es) 2002-11-28 2005-07-25 Astrazeneca Ab Oxazolidinonas como agentes antibacterianos.
TW200500360A (en) * 2003-03-01 2005-01-01 Astrazeneca Ab Hydroxymethyl compounds
US8324398B2 (en) 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
PT1656370E (pt) 2003-06-03 2012-11-29 Rib X Pharmaceuticals Inc Compostos biaril-heterocíclicos e métodos de os produzir e de os utilizar
JP4777246B2 (ja) * 2003-07-29 2011-09-21 リブ−エックス ファーマシューティカルズ,インコーポレイテッド ビアリールオキサゾリジノンの合成方法
EP1660465B1 (en) * 2003-07-29 2014-12-17 Melinta Therapeutics, Inc. Process for the synthesis of biaryl oxazolidinones
AR046782A1 (es) 2003-12-17 2005-12-21 Rib X Pharmaceuticals Inc Compuestos heterociclicos de biarilo halogenados, composiciones farmaceuticas que los contienen, metodos para su elaboracion y su uso como medicamentos.
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
EP1723159B1 (en) 2004-02-27 2019-06-12 Melinta Therapeutics, Inc. Macrocyclic compounds and methods of making and using the same
US20080064689A1 (en) * 2004-05-25 2008-03-13 Astrazeneca Ab 3-[4-(6-Pyridin-3-Yl)-3-Phenyl] -5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones as Antibacterial Agents
EP1753753A1 (en) * 2004-05-25 2007-02-21 AstraZeneca AB 3-(4-(2-dihydroisoxazol-3-ylpyrdin-5-yl)phenyl)-5-triazol-1-ylmethyloxazolidin-2-one derivatives as mao inhibitors for the treatment of bacterial infections
KR101394307B1 (ko) 2005-06-08 2014-05-13 멜린타 테라퓨틱스, 인크. 트리아졸의 합성 방법
RU2556234C2 (ru) 2008-10-10 2015-07-10 Траюс Терапьютикс Способы получения оксазолидинонов и содержащих их композиций
SG173497A1 (en) * 2009-02-03 2011-09-29 Trius Therapeutics Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
US8580767B2 (en) * 2009-05-28 2013-11-12 Trius Therapeutics, Inc. Oxazolidinone containing dimer compounds, compositions and methods to make and use
US9234054B2 (en) * 2011-12-19 2016-01-12 Saudi Basic Industries Corporation Process for the preparation of metallocene complexes
PT2800754T (pt) * 2011-12-19 2017-08-18 Saudi Basic Ind Corp (Sabic) Processo para a preparação de complexos metalocenos
WO2021000297A1 (en) 2019-07-03 2021-01-07 Merck Sharp & Dohme Corp. Compounds and methods of use thereof as antibacterial agents
CN113149924B (zh) * 2021-03-29 2023-11-03 苏州大学 一种异噁唑啉的简单制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
DE4425613A1 (de) * 1994-07-20 1996-01-25 Bayer Ag 5-gliedrige Heteroaryl-oxazolidinone
JP2003535860A (ja) * 2000-06-05 2003-12-02 ドン・ア・ファーム・カンパニー・リミテッド 新規なオキサゾリジノン誘導体及びその製造方法
DK1427711T3 (da) * 2001-09-11 2005-10-17 Astrazeneca Ab Oxazolidinon og/eller isoxazolinderivater som antibakterielle midler
GB0227701D0 (en) * 2002-11-28 2003-01-08 Astrazeneca Ab Chemical compounds

Also Published As

Publication number Publication date
AU2003302404A1 (en) 2004-06-18
WO2004048392A1 (en) 2004-06-10
HK1079794A1 (zh) 2006-04-13
IL168747A0 (en) 2009-02-11
CA2507468A1 (en) 2004-06-10
BR0316688A (pt) 2005-10-18
NO20052534L (no) 2005-08-22
NO20052534D0 (no) 2005-05-26
KR20050085193A (ko) 2005-08-29
EP1567532A1 (en) 2005-08-31
AU2003302404B2 (en) 2008-06-19
MXPA05005651A (es) 2005-07-27
JP2006508192A (ja) 2006-03-09
SA04250088A (ar) 2005-12-03
NZ540147A (en) 2008-03-28
US20060116400A1 (en) 2006-06-01

Similar Documents

Publication Publication Date Title
TW200533666A (en) Chemical compounds
AU2009305203B2 (en) Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
CA3165148A1 (en) Pyrazolyl derivatives useful as anti-cancer agents
US7498350B2 (en) Oxazolidinones as antibacterial agents
US20060058317A1 (en) Oxazolidinone derivatives as antibacterial
US20100305093A1 (en) Inhibitors of mTOR and Methods of Making and Using
TW200304821A (en) Chemical compounds
EP1446403B1 (en) Aryl substituted oxazolidinones with antibacterial activity
WO2014111871A1 (en) 4,5-dihydroisoxazole derivatives as nampt inhibitors
TW200940537A (en) Heterocyclic urea derivatives and methods of use thereof
TW202102495A (zh) Eed及prc2調節劑之巨環唑并吡啶衍生物
US20060058314A1 (en) Oxazolidinone derivatives and their use as antibacterial agents
TW200403241A (en) Chemical compounds
US20240398811A1 (en) Prc2 inhibitors for use in treating blood disorders
US20060052399A1 (en) Oxazolidinone derivatives as antibacterial agents
US20060116389A1 (en) Antibacterial oxazolidinones
JP2008500319A (ja) 細菌感染症の治療のためのmao阻害剤としての3−(4−(2−ジヒドロイソオキサゾール−3−イルピリジン−5−イル)フェニル−5−トリアゾール−1−イルメチルオキサゾリジン−2−オン誘導体
ZA200504309B (en) Oxazolidinones as antibacterial agents.